admin
Washington D.C. – In a move poised to reshape the landscape of agricultural chemical production and intensify ongoing debates over public health and environmental policy, President Donald Trump late Wednesday, February 19, 2026, issued an executive order directing the Secretary of Agriculture to significantly increase the domestic supply of glyphosate, the active ingredient in the widely used herbicide Roundup. The directive, framed under the imperative of national security, also targets elemental phosphorus, a critical precursor for glyphosate, emphasizing the need for robust domestic mining and manufacturing capabilities. This executive action arrives at a contentious juncture, coinciding with a proposed multi-billion-dollar settlement from Bayer related to thousands of glyphosate-linked lawsuits and amidst legislative efforts to grant the company immunity.
The executive order, titled "Promoting the National Defense by Ensuring an Adequate Supply of Elemental Phosphorus and Glyphosate-Based Herbicides," mandates the Secretary of Agriculture to consult with the Secretary of War (Secretary of Defense) to identify and secure the necessary materials, services, and facilities across the nation to ensure an uninterrupted and adequate supply of these agricultural essentials. A significant clause within the order explicitly waives the liability of companies complying with its directives and further stipulates that any subsequent rules or regulations issued under this section must not jeopardize the corporate viability of domestic producers of elemental phosphorus or glyphosate-based herbicides.
President Trump underscored the perceived indispensable role of glyphosate in the nation’s agricultural framework, stating within the order, "As the most widely used crop protection tools in United States agriculture, glyphosate-based herbicides are a cornerstone of this Nation’s agricultural productivity and rural economy, allowing United States farmers and ranchers to maintain high yields and low production costs." This framing of agricultural chemicals as vital to national defense signals a strategic pivot by the administration, linking food security and agricultural input stability directly to broader geopolitical and economic resilience.
The Strategic Imperative: Securing the Glyphosate Supply Chain
At the heart of the executive order’s ambition is a push for greater self-reliance in the production of elemental phosphorus, a key raw material. Currently, Bayer, the multinational pharmaceutical and life sciences company that acquired Monsanto, the original developer of Roundup, largely relies on imported phosphate for its glyphosate production. Its primary domestic source, a long-standing mine in Idaho, is nearing depletion. This dependency on foreign sources for critical agricultural inputs is the stated rationale behind the "national security" justification, aiming to mitigate potential supply chain disruptions or geopolitical pressures.
The timing of this order is particularly notable given recent developments in phosphate mining. Just four months prior, in October, the Trump administration’s Bureau of Land Management (BLM) approved Bayer’s contentious proposal to construct a new phosphate mine in Idaho. This new facility, spanning over 1,800 acres of both public and private land, is intended to replace the nearly exhausted existing mine and secure a domestic source for Bayer’s operations. The executive order essentially solidifies federal support for this expansion, indicating a concerted effort to facilitate increased glyphosate output through guaranteed access to raw materials.
Elemental phosphorus is not merely a component; it is a fundamental building block for glyphosate. Phosphate rock, mined from the earth, is processed to yield elemental phosphorus, which then undergoes a series of chemical reactions to synthesize glyphosate. The environmental footprint of phosphate mining is substantial, involving large-scale land disturbance, significant energy consumption, and the potential for water and soil contamination, including the release of radioactive byproducts like uranium and radium naturally present in phosphate ore. The prospect of expanded mining operations, even if domestically driven, raises significant environmental concerns among conservationists and local communities.
Glyphosate’s Controversial Journey: From Innovation to Legal Battleground
Glyphosate, first introduced by Monsanto in 1974 under the brand name Roundup, revolutionized weed control in agriculture. Its broad-spectrum efficacy and relatively low acute toxicity led to its widespread adoption, especially after the introduction of "Roundup Ready" genetically modified crops in the mid-1990s, which are resistant to the herbicide. This innovation allowed farmers to spray glyphosate directly over crops, simplifying weed management and contributing to the proliferation of no-till farming practices, which reduce soil erosion. Today, glyphosate remains the most widely used herbicide globally, with an estimated 280 million pounds applied annually in the U.S. alone across agricultural, commercial, and residential settings.
Despite its agricultural ubiquity, glyphosate has been mired in controversy regarding its health and environmental impacts. The debate intensified dramatically in 2015 when the International Agency for Research on Cancer (IARC), a specialized cancer agency of the World Health Organization (WHO), classified glyphosate as "probably carcinogenic to humans" (Group 2A), citing evidence of non-Hodgkin’s lymphoma. This classification, though contested by regulatory bodies like the U.S. Environmental Protection Agency (EPA) which maintains glyphosate is "not likely to be carcinogenic to humans," sparked a wave of lawsuits from individuals claiming their exposure to Roundup caused their cancer.
Bayer’s 2018 acquisition of Monsanto for approximately $63 billion unexpectedly burdened the German conglomerate with immense legal liabilities stemming from these glyphosate lawsuits. Tens of thousands of plaintiffs have filed claims, alleging that Monsanto failed to adequately warn consumers about the potential cancer risks associated with Roundup. Initial landmark verdicts, such as the Johnson v. Monsanto case in 2018, resulted in substantial awards to plaintiffs, further escalating Bayer’s legal exposure and significantly impacting its stock value.
This week, against the backdrop of the executive order, Bayer proposed a $7.25 billion settlement to resolve a significant portion of the ongoing lawsuits. This settlement, if approved, aims to bring closure to thousands of these cases, though it does not admit fault or liability on Bayer’s part. It represents a substantial financial commitment from the company, reflecting the immense pressure from continuous litigation and the desire to mitigate future financial uncertainties.
Legislative and Judicial Interventions: A Multi-Front Battle
The executive order is not an isolated event but rather a piece of a larger, multi-pronged effort by the Trump administration and some congressional Republicans to protect glyphosate’s market position and shield its manufacturers from legal challenges. Last week, House Republicans included an immunity clause in a draft farm bill. Such a clause, if enacted, would effectively prevent future lawsuits against glyphosate manufacturers based on claims of inadequate labeling or health risks, by establishing federal preemption over state-level tort claims regarding pesticide labeling. This legislative maneuver mirrors previous attempts by Bayer to change state and federal laws to block future lawsuits, demonstrating a concerted strategy to solidify the legal standing of glyphosate.
The judicial front also remains active. The U.S. Supreme Court is scheduled to hear a pivotal case in April, Bayer AG v. Hardeman, which could have profound implications for the ongoing litigation. In this case, the Trump administration has explicitly sided with Bayer, arguing that federal law (specifically, the Federal Insecticide, Fungicide, and Rodenticide Act, or FIFRA) preempts state-level claims that Roundup labels should have included cancer warnings. A ruling in favor of Bayer could effectively shut down many existing and future state-level lawsuits, providing a significant legal victory for the company. The executive order, by signaling robust federal support for glyphosate production, further aligns the administration’s policy with the legal and legislative interests of its primary manufacturer.
Diverse Reactions and the Political Undercurrents
The executive order was met with a spectrum of reactions, revealing deep divisions within political and public health spheres. House Agriculture Chair G.T. Thompson (R-Pennsylvania) swiftly issued a statement applauding the order as a "vital step forward" in ensuring farmers retain access to glyphosate, echoing the sentiment that the herbicide is essential for agricultural productivity and economic stability.
However, the directive provoked significant dismay among public health advocates and environmental groups. Prominent supporters of Secretary of Health and Human Services Robert F. Kennedy Jr.’s "Make America Healthy Again" (MAHA) movement voiced strong opposition. On social media platforms, toxicologist Alexandra Muñoz condemned the order as "outrageous and unacceptable," while anti-glyphosate advocate Kelly Ryerson emphasized that glyphosate is "the pesticide MAHA cares about most," highlighting its central role in their advocacy against chemical exposures.
The reaction from Robert F. Kennedy Jr. himself, however, presented a curious dichotomy. Despite his public persona as a staunch environmental advocate and critic of corporate influence in public health, Kennedy reportedly told The New York Times that he supported the president’s decision. This apparent contradiction between Kennedy’s stated position and the widespread dismay among his core supporters immediately drew scrutiny and criticism.
Ken Cook, President of the Environmental Working Group (EWG), articulated this disillusionment sharply. In a statement, Cook remarked, "If anyone still wondered whether ‘Make America Healthy Again’ was a genuine commitment to protecting public health or a scam concocted by President Trump and RFK Jr. to rally health-conscious voters in 2024, today’s decision answers that question." This sentiment suggests that for many public health advocates, the executive order serves as a litmus test, revealing what they perceive as a prioritization of corporate agricultural interests over public health concerns. Environmental groups further warned that increasing domestic mining for phosphate and continued reliance on glyphosate would exacerbate environmental degradation, contribute to biodiversity loss, and potentially increase human exposure to a probable carcinogen.
Implications and the Path Forward
The executive order carries multifaceted implications for the U.S. agricultural sector, environmental policy, and public health. Economically, it promises federal backing for Bayer’s domestic operations, potentially bolstering its financial stability in the face of legal challenges and ensuring a consistent supply of a critical agricultural input. For farmers, the order aims to stabilize access to glyphosate, potentially mitigating price volatility and supply chain risks associated with imported raw materials.
Environmentally, the directive signals a commitment to expanding extractive industries, particularly phosphate mining, with potential long-term consequences for ecosystems, water quality, and land use. The environmental review processes for such expansions, even under federal mandate, are likely to face intense scrutiny and legal challenges from advocacy groups.
From a public health perspective, the order entrenches the use of a chemical whose safety remains a subject of intense scientific and legal debate. While regulatory bodies like the EPA continue to affirm glyphosate’s safety when used as directed, the IARC classification and the sheer volume of cancer lawsuits highlight persistent public concern and scientific disagreement. The administration’s move to promote its domestic production rather than explore alternatives could be seen as a setback for those advocating for a transition to less chemically intensive farming practices.
Legally, the executive order, combined with legislative efforts in the Farm Bill and the upcoming Supreme Court case, represents a comprehensive strategy to insulate glyphosate from legal challenges and solidify its market presence. The liability waiver and corporate viability clauses within the order are powerful protections for manufacturers, potentially shifting the balance of power further away from plaintiffs seeking damages for alleged harm.
As the Supreme Court prepares to hear arguments in April, and as the Farm Bill progresses through Congress, the implications of this executive order will unfold in a complex legal and political landscape. The directive to boost domestic glyphosate and elemental phosphorus production, under the banner of national security, marks a significant and potentially enduring shift in federal policy, with profound consequences for American agriculture, health, and environment for years to come.
